Abbott's (ABT) Q4 Earnings and Revenues Beat Estimates

Abbott's (ABT) COVID-19 testing-related sales in Q4 increased on demand for BinaxNOW, Panbio and ID NOW rapid testing platforms.

Related Keywords

China ,Boston ,Massachusetts ,United States ,India ,Russia ,Henry Schein ,Abbott Laboratories ,Henry Schein Inc ,Zacks Investment Research ,Core Laboratory Diagnostics ,Boston Beer Company ,Research Sheraz Mian ,Nvidia ,Pharmaceuticals Division ,Healthcare Services Inc ,Hologic Inc ,Zacks Consensus Estimate ,Established Pharmaceuticals Division ,Medical Devices ,Freestyle Libre ,Laboratories Price ,Adult Nutrition ,Laboratory Diagnostics ,Molecular Diagnostics ,Vcare Diagnostics ,Diabetes Care ,Within Adult Nutrition ,Zacks Rank ,Strong Buy ,Best Pick ,Zack Stocks Set ,Our Top Stock ,Zacks Investment ,Stocks ,Finance ,